Market Value2,964,695,194
Total Holdings51
File Date2023-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
EWTX / Edgewise Therapeutics, Inc.
MORF / Morphic Holding, Inc.
JAZZ / Jazz Pharmaceuticals plc
RVMD / Revolution Medicines, Inc.
ALGS / Aligos Therapeutics, Inc.
RVMD / Revolution Medicines, Inc. Call
SWTX / SpringWorks Therapeutics, Inc.
THRD / Third Harmonic Bio, Inc.
JANX / Janux Therapeutics, Inc.
ZYME / Zymeworks Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
ORIC / ORIC Pharmaceuticals, Inc.
TNGX / Tango Therapeutics, Inc.
NGM / NGM Biopharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.
OVID / Ovid Therapeutics Inc.
AVIR / Atea Pharmaceuticals, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
PRME / Prime Medicine, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
NUVB / Nuvation Bio Inc.
MRSN / Mersana Therapeutics, Inc.
ALLK / Allakos Inc.
PRLD / Prelude Therapeutics Incorporated
KURA / Kura Oncology, Inc.
RLAY / Relay Therapeutics, Inc.
SLRN / Acelyrin, Inc.
SRPT / Sarepta Therapeutics, Inc.
ANAB / AnaptysBio, Inc.
PRTA / Prothena Corporation plc
TCRX / TScan Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
ALEC / Alector, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
ALLO / Allogene Therapeutics, Inc.
GBIO / Generation Bio Co.
CMAXW / CareMax Inc - Warrants (08/06/2026)
VYGR / Voyager Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc. Call
PHAT / Phathom Pharmaceuticals, Inc.
HOOK / HOOKIPA Pharma Inc.
KURA / Kura Oncology, Inc. Call
PSTX / Poseida Therapeutics, Inc.
KRON / Kronos Bio, Inc.
JNJ / Johnson & Johnson Call
DYN / Dyne Therapeutics, Inc.
AGLE / Aeglea BioTherapeutics Inc
SYRE / Spyre Therapeutics, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
BPMC / Blueprint Medicines Corporation
GRPH / Graphite Bio, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
ZNTL / Zentalis Pharmaceuticals, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
PRQR / ProQR Therapeutics N.V.
NMRA / Neumora Therapeutics, Inc.
GOSS / Gossamer Bio, Inc.
ARVN / Arvinas, Inc.
TPST / Tempest Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
XNCR / Xencor, Inc.